Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 075616
Company: WATSON LABS
Company: WATSON LABS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NIZATIDINE | NIZATIDINE | 150MG | CAPSULE;ORAL | Prescription | AB | No | No |
NIZATIDINE | NIZATIDINE | 300MG | CAPSULE;ORAL | Prescription | AB | No | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
07/09/2002 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/75616ta.pdf |
NIZATIDINE
CAPSULE;ORAL; 150MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
NIZATIDINE | NIZATIDINE | 150MG | CAPSULE;ORAL | Prescription | No | AB | 077314 | DR REDDYS LABS LTD |
NIZATIDINE | NIZATIDINE | 150MG | CAPSULE;ORAL | Prescription | No | AB | 076178 | EPIC PHARMA LLC |
NIZATIDINE | NIZATIDINE | 150MG | CAPSULE;ORAL | Prescription | No | AB | 090618 | GLENMARK PHARMS INC |
NIZATIDINE | NIZATIDINE | 150MG | CAPSULE;ORAL | Prescription | No | AB | 075616 | WATSON LABS |
CAPSULE;ORAL; 300MG
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
NIZATIDINE | NIZATIDINE | 300MG | CAPSULE;ORAL | Prescription | No | AB | 077314 | DR REDDYS LABS LTD |
NIZATIDINE | NIZATIDINE | 300MG | CAPSULE;ORAL | Prescription | No | AB | 076178 | EPIC PHARMA LLC |
NIZATIDINE | NIZATIDINE | 300MG | CAPSULE;ORAL | Prescription | No | AB | 090618 | GLENMARK PHARMS INC |
NIZATIDINE | NIZATIDINE | 300MG | CAPSULE;ORAL | Prescription | No | AB | 075616 | WATSON LABS |